Galera Therapeutics, Inc. - stock earnings
GRTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -15.1 million USD | ? USD |
| 2023Q2 | -20.7 million USD | ? USD |
| 2023Q1 | -25.8 million USD | ? USD |
| 2022Q4 | -16.2 million USD | ? USD |
| 2022Q3 | -19.1 million USD | ? USD |
| 2022Q2 | -17.2 million USD | ? USD |
| 2022Q1 | -17.7 million USD | ? USD |
| 2021Q4 | -16.8 million USD | ? USD |
| 2021Q3 | -22.6 million USD | ? USD |
| 2021Q2 | -22.4 million USD | ? USD |
| 2021Q1 | -18.7 million USD | ? USD |
| 2020Q4 | -20.1 million USD | ? USD |
| 2020Q3 | -17.1 million USD | ? USD |
| 2020Q2 | -18.7 million USD | ? USD |
| 2020Q1 | -18.4 million USD | ? USD |
| 2019Q4 | -16.7 million USD | ? USD |
| 2019Q3 | -13.4 million USD | ? USD |
| 2019Q2 | -11.6 million USD | ? USD |
| 2019Q1 | -10.3 million USD | ? USD |
| 2018Q4 | -8.6 million USD | ? USD |
| 2018Q3 | -5.2 million USD | ? USD |
GRTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -69.7 million USD | ? USD |
| 2022 | -62.2 million USD | ? USD |
| 2021 | -87.7 million USD | ? USD |
| 2020 | -74.2 million USD | ? USD |
| 2019 | -51.9 million USD | ? USD |
| 2018 | -23.7 million USD | ? USD |
| 2017 | -23.5 million USD | ? USD |
GRTX
Price: $0.19
52 week price:
Earnings Per Share: -1.88 USD
P/E Ratio: -0.09
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 52746
Market Capitalization: 9.0 million